Kazazian Asset Management, LLC - Q4 2018 holdings

$74 Million is the total value of Kazazian Asset Management, LLC's 64 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 50.0% .

 Value Shares↓ Weighting
GM SellGENERAL MTRS CO$4,352,000
-41.0%
130,102
-40.6%
5.88%
-14.8%
CLNY SellCOLONY CAP INC NEW$3,906,000
-42.0%
834,527
-24.6%
5.28%
-16.4%
GOOG SellALPHABET INCcap stk cl c$3,421,000
-27.2%
3,303
-16.1%
4.62%
+5.1%
BIIB SellBIOGEN INC$2,508,000
-41.5%
8,336
-31.3%
3.39%
-15.6%
EEM SellISHARES TRmsci emg mkt etf$2,268,000
-79.6%
58,065
-77.5%
3.06%
-70.5%
ALXN SellALEXION PHARMACEUTICALS INC$1,934,000
-53.0%
19,862
-33.0%
2.61%
-32.3%
MLPA SellGLOBAL X FDSglbl x mlp etf$1,366,000
-62.6%
178,135
-53.4%
1.85%
-46.0%
BHC SellBAUSCH HEALTH COS INC$1,258,000
-62.2%
68,121
-47.5%
1.70%
-45.5%
DIS SellDISNEY WALT CO$1,213,000
-13.5%
11,058
-7.8%
1.64%
+24.7%
BMY SellBRISTOL MYERS SQUIBB CO$1,000,000
-44.1%
19,247
-33.2%
1.35%
-19.3%
BPMC SellBLUEPRINT MEDICINES CORP$999,000
-55.9%
18,528
-36.2%
1.35%
-36.4%
EXPE SellEXPEDIA GROUP INC$951,000
-31.0%
8,441
-20.1%
1.28%
-0.5%
NS SellNUSTAR ENERGY LP$805,000
-41.8%
38,447
-22.7%
1.09%
-16.0%
AUPH SellAURINIA PHARMACEUTICALS INC$798,000
-29.4%
117,056
-31.3%
1.08%
+1.8%
RESI SellFRONT YD RESIDENTIAL CORP$738,000
-50.2%
84,487
-38.2%
1.00%
-28.2%
SLV SellISHARES SILVER TRUSTishares$686,000
-32.2%
47,227
-36.0%
0.93%
-2.2%
ABT SellABBOTT LABS$662,000
-6.4%
9,158
-5.0%
0.90%
+35.2%
CS SellCREDIT SUISSE GROUPsponsored adr$594,000
-57.2%
54,706
-41.2%
0.80%
-38.3%
ZGNX SellZOGENIX INC$427,000
-31.4%
11,704
-6.6%
0.58%
-1.0%
BLUE SellBLUEBIRD BIO INC$387,000
-57.7%
3,902
-37.7%
0.52%
-39.0%
MRK SellMERCK & CO INC$372,000
-54.6%
4,874
-57.8%
0.50%
-34.5%
GWPH SellGW PHARMACEUTICALS PLCads$371,000
-51.0%
3,813
-13.0%
0.50%
-29.3%
IBB SellISHARES TRnasdaq biotech$359,000
-60.8%
3,722
-50.4%
0.48%
-43.4%
INCY SellINCYTE CORP$347,000
-42.7%
5,464
-37.7%
0.47%
-17.4%
BMRN SellBIOMARIN PHARMACEUTICAL INC$332,000
-43.2%
3,902
-35.2%
0.45%
-17.9%
AERI SellAERIE PHARMACEUTICALS INC$326,000
-63.5%
9,021
-37.9%
0.44%
-47.3%
V SellVISA INC$323,000
-69.3%
2,450
-65.0%
0.44%
-55.7%
BCS SellBARCLAYS PLCadr$322,000
-76.4%
42,678
-72.0%
0.44%
-65.9%
TSRO SellTESARO INC$314,000
-19.7%
4,234
-57.8%
0.42%
+15.8%
SALT SellSCORPIO BULKERS INC$293,000
-36.6%
52,943
-16.9%
0.40%
-8.5%
EIGI SellENDURANCE INTL GROUP HLDGS I$277,000
-71.4%
41,587
-62.2%
0.37%
-58.7%
GMWSB SellGENERAL MTRS CO*w exp 07/10/201$229,000
-8.4%
14,403
-5.0%
0.31%
+32.1%
ARRY SellARRAY BIOPHARMA INC$222,000
-21.8%
15,564
-16.8%
0.30%
+12.8%
GDX SellVANECK VECTORS ETF TRgold miners etf$218,000
-7.2%
10,327
-18.6%
0.30%
+34.1%
GBT SellGLOBAL BLOOD THERAPEUTICS IN$208,000
-32.9%
5,071
-37.7%
0.28%
-3.1%
YNDX SellYANDEX N V$202,000
-27.1%
7,380
-12.3%
0.27%
+5.4%
SPPI SellSPECTRUM PHARMACEUTICALS INC$154,000
-75.6%
17,554
-53.3%
0.21%
-64.9%
DOFSQ SellDIAMOND OFFSHORE DRILLING IN$122,000
-79.3%
12,967
-56.0%
0.16%
-70.2%
VKTX SellVIKING THERAPEUTICS INC$90,000
-72.5%
11,703
-37.7%
0.12%
-60.1%
ZYNE SellZYNERBA PHARMACEUTICALS INC$35,000
-77.1%
11,703
-37.7%
0.05%
-67.1%
MTLPR SellMECHEL PAOspon adr pfd$25,000
-19.4%
38,123
-5.0%
0.03%
+17.2%
GMOLQ SellGENERAL MOLY INC$4,000
-42.9%
17,982
-5.0%
0.01%
-28.6%
OMED ExitONCOMED PHARMACEUTICALS INC$0-31,475
-100.0%
-0.06%
SAN ExitBANCO SANTANDER SAadr$0-13,541
-100.0%
-0.06%
TGTX ExitTG THERAPEUTICS INC$0-12,528
-100.0%
-0.07%
SNSS ExitSUNESIS PHARMACEUTICALS INC$0-35,000
-100.0%
-0.07%
AXGT ExitAXOVANT SCIENCES LTD$0-31,320
-100.0%
-0.07%
NERV ExitMINERVA NEUROSCIENCES INC$0-10,026
-100.0%
-0.12%
CLF ExitCLEVELAND CLIFFS INC$0-10,785
-100.0%
-0.13%
SYRS ExitSYROS PHARMACEUTICALS INC$0-13,266
-100.0%
-0.15%
SRRA ExitSIERRA ONCOLOGY INC$0-118,295
-100.0%
-0.19%
WFTIQ ExitWEATHERFORD INTL PLC$0-80,401
-100.0%
-0.20%
BTU ExitPEABODY ENERGY CORP NEW$0-6,594
-100.0%
-0.22%
INTC ExitINTEL CORP$0-5,160
-100.0%
-0.23%
GDXJ ExitVANECK VECTORS ETF TRjr gold miners e$0-8,903
-100.0%
-0.23%
MYL ExitMYLAN N V$0-7,000
-100.0%
-0.24%
MDGL ExitMADRIGAL PHARMACEUTICALS INC$0-1,253
-100.0%
-0.25%
DCPH ExitDECIPHERA PHARMACEUTICALS IN$0-7,000
-100.0%
-0.25%
ACOR ExitACORDA THERAPEUTICS INC$0-14,454
-100.0%
-0.27%
AAMC ExitALTISOURCE ASSET MGMT CORP$0-5,017
-100.0%
-0.28%
PTEN ExitPATTERSON UTI ENERGY INC$0-17,867
-100.0%
-0.29%
COG ExitCABOT OIL & GAS CORP$0-14,205
-100.0%
-0.30%
UTHR ExitUNITED THERAPEUTICS CORP DEL$0-2,506
-100.0%
-0.30%
ARNA ExitARENA PHARMACEUTICALS INC$0-7,000
-100.0%
-0.30%
ECYT ExitENDOCYTE INC$0-18,794
-100.0%
-0.31%
PE ExitPARSLEY ENERGY INCcl a$0-11,881
-100.0%
-0.33%
PTLA ExitPORTOLA PHARMACEUTICALS INC$0-13,155
-100.0%
-0.33%
PYPL ExitPAYPAL HLDGS INC$0-4,000
-100.0%
-0.33%
NTLA ExitINTELLIA THERAPEUTICS INC$0-12,530
-100.0%
-0.34%
APA ExitAPACHE CORP$0-7,593
-100.0%
-0.34%
LJPC ExitLA JOLLA PHARMACEUTICAL CO$0-18,076
-100.0%
-0.34%
PXD ExitPIONEER NAT RES CO$0-2,144
-100.0%
-0.35%
NBL ExitNOBLE ENERGY INC$0-12,864
-100.0%
-0.38%
CORI ExitCORIUM INTL INC$0-43,854
-100.0%
-0.39%
CXO ExitCONCHO RES INC$0-2,949
-100.0%
-0.42%
GSK ExitGLAXOSMITHKLINE PLCsponsored adr$0-12,530
-100.0%
-0.47%
NKTR ExitNEKTAR THERAPEUTICS$0-8,601
-100.0%
-0.49%
CLLS ExitCELLECTIS S Asponsored ads$0-18,792
-100.0%
-0.50%
PBYI ExitPUMA BIOTECHNOLOGY INC$0-15,035
-100.0%
-0.64%
ORCL ExitORACLE CORP$0-14,716
-100.0%
-0.71%
TRGP ExitTARGA RES CORP$0-13,944
-100.0%
-0.74%
XLF ExitSELECT SECTOR SPDR TRsbi int-finl$0-40,000
-100.0%
-1.03%
PZZA ExitPAPA JOHNS INTL INC$0-27,500
-100.0%
-1.32%
SPY ExitSPDR S&P 500 ETF TRtr unit$0-5,508
-100.0%
-1.50%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
GENERAL MTRS CO20Q3 20199.4%
APPLE INC20Q3 20198.8%
CITIGROUP INC20Q3 20196.2%
ALIBABA GROUP HLDG LTD20Q3 20192.6%
EQUUS TOTAL RETURN INC20Q3 20190.1%
MECHEL PAO20Q3 20190.1%
GENERAL MOLY INC20Q3 20190.0%
GENERAL MTRS CO19Q2 20190.5%
SPDR S&P 500 ETF TR17Q3 201951.5%
BAIDU INC17Q3 20196.5%

View Kazazian Asset Management, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Kazazian Asset Management, LLC Q4 2018 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
GEE Group Inc.February 14, 2022182,5550.2%
Bonds.com Group, Inc.July 10, 201328,57110.5%

View Kazazian Asset Management, LLC's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2022-02-14
SC 13G2021-04-29
13F-HR2019-11-14
13F-HR2019-08-14
13F-HR2019-05-15
13F-HR2019-02-14
13F-HR2018-11-14
13F-HR2018-08-14
13F-HR2018-05-15
13F-HR2018-02-15

View Kazazian Asset Management, LLC's complete filings history.

Compare quarters

Export Kazazian Asset Management, LLC's holdings